BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31305014)

  • 1. Blood CD9
    Brosseau C; Danger R; Durand M; Durand E; Foureau A; Lacoste P; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Magnan A; Brouard S;
    Am J Transplant; 2019 Nov; 19(11):3162-3175. PubMed ID: 31305014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Transplant Patients Show a Dissimilar Peripheral B-Cell Subset Ratio Compared With Healthy Controls.
    Schreurs I; Meek B; Hijdra D; Rodriguez Gomez M; van Moorsel CHM; Luijk HD; Kwakkel-van Erp JM; Oudijk EJ; van Kessel DA; Grutters JC
    Exp Clin Transplant; 2020 Apr; 18(2):234-241. PubMed ID: 32279657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High circulating CD4
    Durand M; Lacoste P; Danger R; Jacquemont L; Brosseau C; Durand E; Tilly G; Loy J; Foureau A; Royer PJ; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Degauque N; Magnan A; Brouard S;
    J Heart Lung Transplant; 2018 Jun; 37(6):770-781. PubMed ID: 29571601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
    DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
    Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD; Galbán CJ; Vanaudenaerde BM
    Am J Transplant; 2016 Nov; 16(11):3262-3269. PubMed ID: 27367568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.
    Liu X; Yue Z; Yu J; Daguindau E; Kushekhar K; Zhang Q; Ogata Y; Gafken PR; Inamoto Y; Gracon A; Wilkes DS; Hansen JA; Lee SJ; Chen JY; Paczesny S
    Am J Transplant; 2016 Aug; 16(8):2342-51. PubMed ID: 26887344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.
    White SR; Floreth T; Liao C; Bhorade SM
    PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
    Furuya Y; Jayarajan SN; Taghavi S; Cordova FC; Patel N; Shiose A; Leotta E; Criner GJ; Guy TS; Wheatley GH; Kaiser LR; Toyoda Y
    Am J Transplant; 2016 Aug; 16(8):2334-41. PubMed ID: 26833657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution.
    Bergantini L; d'Alessandro M; De Vita E; Perillo F; Fossi A; Luzzi L; Paladini P; Perrone A; Rottoli P; Sestini P; Bargagli E; Bennett D
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection.
    Gunasekaran M; Xu Z; Nayak DK; Sharma M; Hachem R; Walia R; Bremner RM; Smith MA; Mohanakumar T
    Am J Transplant; 2017 Feb; 17(2):474-484. PubMed ID: 27278097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
    Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
    Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].
    Yang S; Abuduwufuer A; Lv W; Bao F; Hu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):496-502. PubMed ID: 32517455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
    Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation.
    Budding K; van de Graaf EA; Paantjens AW; Kardol-Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Otten HG
    Transpl Immunol; 2015 Jun; 32(3):195-200. PubMed ID: 25841614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.